Sativa Wellness - Rule 2.9 Announcement
RNS Number : 8259A
Sativa Wellness Group Inc.
01 October 2020
 

 

 

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART, IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OF THAT JURISDICTION

FOR IMMEDIATE RELEASE

 1 October 2020

SATIVA WELLNESS GROUP INC.
("Sativa Wellness" or the "Company")

Rule 2.9 Announcement

In accordance with Rule 2.9 of the City Code on Takeovers and Mergers, the Company confirms that, as at the close of business on 30 September 2020, being the last business day prior to the date of this announcement, it had 302,592,941 common shares of no par value each in issue and admitted to trading on the AQSE Growth Market.  Sativa Wellness holds no common shares in treasury.  Accordingly, the total number of voting rights in Sativa Wellness is 302,592,941.  The International Securities Identification Number ('ISIN') for Sativa Wellness's ordinary shares is CA80403E1043.

 

Henry Lees-Buckley 

Chief Executive Officer

Sativa Wellness Group Inc.

+44 (0) 20 7971 1255

enquiries@sativawellnessgroup.com

 

 www.sativawellnessgroup.com

 

Joseph Colliver

Chief Financial Officer

Sativa Wellness Group Inc.

+44 (0) 20 7971 1255

enquiries@sativawellnessgroup.com

 

www.sativawellnessgroup.com

 

 

Jason Dussault

Investor Relations and Communications

Sativa Wellness Group Inc. (formerly Stillcanna Inc.jason@sativawellnessgroup.com www.sativawellnessgroup.com

 

 

AQSE Growth Market Corporate Adviser

Corporate Finance 

Guy Miller/Allie Feuerlein

Peterhouse Capital Limited

 

 

This information is provided by RNS, the news service of the . RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NEXBGBDGLSGDGGB ]]>